Ignite Creation Date:
2025-12-24 @ 4:46 PM
Ignite Modification Date:
2026-01-29 @ 12:33 PM
Study NCT ID:
NCT07018050
Status:
RECRUITING
Last Update Posted:
2025-09-22
First Post:
2025-06-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Study of QLS32015 Combination Therapy in the Treatment of Multiple Myeloma
Sponsor:
Qilu Pharmaceutical Co., Ltd.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Relapsed or Refractory Multiple Myeloma | View |
Keywords: